C
ADPT icon

Covestor’s Adaptive Biotechnologies ADPT Stock Holding History

Covestor’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
32
+23
+256% +$352 ﹤0.01% 2018
2026
Q1 		$0 Sell
9
-6
-40% -$96 ﹤0.01% 2197
2025
Q4 		$0 Hold
15
– – ﹤0.01% 2215
2025
Q3 		$0 Hold
15
– – ﹤0.01% 2226
2025
Q2 		$0 Sell
15
-1
-6% -$9 ﹤0.01% 2146
2025
Q1 		$0 Sell
16
-7
-30% -$54 ﹤0.01% 2156
2024
Q4 		$0 Buy
23
+2
+10% +$11 ﹤0.01% 2176
2024
Q3 		$0 Sell
21
-12
-36% -$52 ﹤0.01% 2151
2024
Q2 		$0 Buy
33
+19
+136% +$60 ﹤0.01% 2181
2024
Q1 		$0 Sell
14
-1
-7% -$4 ﹤0.01% 2181
2023
Q4 		$0 Sell
15
-2
-12% -$9 ﹤0.01% 2081
2023
Q3 		$0 Sell
17
-2
-11% -$13 ﹤0.01% 2047
2023
Q2 		$0 Sell
19
-1
-5% -$7 ﹤0.01% 2064
2023
Q1 		$0 Hold
20
– – ﹤0.01% 1940
2022
Q4 		$0 Sell
20
-1
-5% -$8 ﹤0.01% 1986
2022
Q3 		$0 Sell
21
-7
-25% -$66 ﹤0.01% 1913
2022
Q2 		$0 Buy
28
+1
+4% +$9 ﹤0.01% 1845
2022
Q1 		$0 Sell
27
-135
-83% -$2.12K ﹤0.01% 2044
2021
Q4 		$5K Buy
+162
New +$4.96K 0.01% 1281

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Covestor's ADPT Position: Q2 2026 in Review

Covestor increased its Adaptive Biotechnologies (ADPT) stake by 256% in Q2 2026, buying an estimated $352 and bringing the position to 32 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Covestor first reported a position in ADPT in Q4 2021 and has held it in 19 quarters since. The position peaked at $5K in Q4 2021. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Covestor held 32 shares of Adaptive Biotechnologies worth $1K as of Q2 2026.
  • Covestor bought 23 Adaptive Biotechnologies shares in Q2 2026, an estimated $352.
  • Adaptive Biotechnologies made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2018 holding.
  • Covestor first reported a position in Adaptive Biotechnologies in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Adaptive Biotechnologies position peaked at $5K in Q4 2021.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.